Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)

National Institutes of Health Nationwide (Federal)

Tell us about your organization and we'll show you whether this grant fits, and why.

Free to start. No credit card required.

Deadline

August 18, 2027

Region

Nationwide (Federal)

Funder type

Federal Government

For

Nonprofits & businesses

Sectors

Health & Human Services

About this program

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional) — U.S. federal funding opportunity (PAR-24-293) from National Institutes of Health. See grants.gov for full eligibility and details.

Official program page Last verified October 5, 2026 by the Happy Grants engine

Is this grant worth your time?

Create a free account and Happy Grants scores this program, and 2,300+ others, against your organization’s profile in about a minute, with the reasons explained.

See your match score, free

Similar grants